1-4 of 4
Linda Schroeder
Close
Sort by
Journal Articles

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

Clinical Trials & Observations
Hongtao Liu, Elizabeth S. Rich, Lucy Godley, Olatoyosi Odenike, Loren Joseph, Susana Marino, Justin Kline, Vu Nguyen, John Cunningham, Richard A. Larson, Paula del Cerro, Linda Schroeder, Lisa Pape, Wendy Stock, Amittha Wickrema, Andrew S. Artz, Koen van Besien
Journal: Blood
Blood (2011) 118 (24): 6438–6445.
https://doi.org/10.1182/blood-2011-08-372508
Published: 2011
Includes: Supplemental data
Journal Articles

Reduced Intensity Conditioning with Combined Haploidentical and Cord Blood Transplantation Results in Rapid Engraftment and Durable Remissions in Hematological Malignancies

Hongtao Liu, MD, PhD, Elizabeth Shima Rich, MD, PhD, Lucy Godley, MD, PhD, Olatoyosi Odenike, MD, Loren Joseph, M.D., Susana Marino, M.D., Justin Kline, MD, Vu H. Nguyen, MD, John M Cunningham, MD, Richard A. Larson, MD, Paula Del Cerro, RN, Linda Schroeder, RN, Lisa Pape, RN, Wendy Stock, MD, Amittha Wickrema, PhD, Andrew Artz, MD MS, Koen M. Van Besien, MD
Journal: Blood
Blood (2011) 118 (21): 830.
https://doi.org/10.1182/blood.V118.21.830.830
Published: 2011
Journal Articles

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab (CMA) Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Determination of MTD and Outcomes.

Koen van Besien, MD, Justin Kline, Lucy A Godley, MD, PhD, Richard A. Larson, MD, Vu H. Nguyen, MD, Olatoyosi Odenike, MD, Elizabeth Shima Rich, MD, PhD, Wendy Stock, MD, Amittha Wickrema, PhD, Scott Allen, BA, Paula del Cerro, Sarah Horowitz, Lisa Pape, RN, Linda Schroeder, RN, Andrew Artz, MD, MS
Journal: Blood
Blood (2009) 114 (22): 197.
https://doi.org/10.1182/blood.V114.22.197.197
Published: 2009
Journal Articles

Allogeneic Hematopoietic Cell Transplantation From Combined Haploidentical Family Members and Unrelated Cord Blood (CB) Can Benefit High Risk Patients Lacking HLA-Identical Donors.

Elizabeth Shima Rich, MD, PhD, Andrew Artz, MD, MS, Theodore Karrison, Ph.D., Lucy A Godley, MD, PhD, Olatoyosi Odenike, MD, Loren Joseph, MD, Justin Kline, MD, Vu H. Nguyen, MD, Guadalupe Martinez, BS, Paula del Cerro, RN, Lisa Pape, RN, Linda Schroeder, RN, Scott Allen, BA, Sarah Horowitz, BA, John Cunningham, MD, Richard A. Larson, MD, Wendy Stock, MD, Amittha Wickrema, PhD, Koen van Besien, MD
Journal: Blood
Blood (2009) 114 (22): 3378.
https://doi.org/10.1182/blood.V114.22.3378.3378
Published: 2009